Ipriflavone, Alfacalcidol with Calcium Carbonate Tablets

Project Image

Therapeutic Indication

Prevention and treatment of osteoporosis
Improvement of bone mineral density
Adjunct therapy in postmenopausal women
Support in calcium and vitamin D deficiency
Reduction of fracture risk
Management of osteopenia
+91 85919 78885

Calcium Citrate + Ipriflavone + Calcitriol + Vitamin D3

Tablet

A synergistic formulation combining calcium citrate, ipriflavone, calcitriol, and vitamin D3 to enhance bone strength, prevent fractures, and manage osteoporosis effectively.

Speciality Bone Health | Osteoporosis Prevention | Postmenopausal Support
Tags Calcium Citrate | Ipriflavone | Calcitriol
Strength
  • Ipriflavone 300 mg
  • Calcitriol 0.25 mcg
  • Calcium Citrate 500 mg
  • Vitmamin D3 5.25 mg
Packing Size
  • 10 Tablets

Check all Tablet Range

Click to know More

Mechanism

Calcium Citrate provides bioavailable calcium; Ipriflavone supports bone formation and reduces resorption; Calcitriol regulates calcium absorption and bone metabolism; Vitamin D3 enhances calcium uptake and bone mineralization.

Pharmacokinetics

  • Absorption: Calcium absorbed in intestine; Alfacalcidol rapidly absorbed orally.
  • Distribution: Calcium distributed to bone and extracellular fluid; Alfacalcidol binds plasma proteins.
  • Metabolism: Alfacalcidol converted in liver to active calcitriol; Ipriflavone metabolized hepatically.
  • Elimination: Calcium excreted via urine and feces; metabolites via bile.
  • Half-life: Alfacalcidol ~3–6 hrs; Calcium varies with intake.

Side Effects

  • Mild gastrointestinal discomfort
  • Hypercalcemia (rare)
  • Allergic reactions

Contraindication

  • Hypercalcemia
  • Renal calculi
  • Hypersensitivity to any component

Interaction

  • Use cautiously with bisphosphonates — medical supervision required
  • Corticosteroids may reduce calcium absorption
  • Risk of hypercalcemia when combined with cardiac glycosides
  • Monitor when taken with other Vitamin D supplements

Warning and Precautions

  • Monitor serum calcium and vitamin D levels during therapy.
  • Use with caution in patients with renal impairment.
  • Not recommended for long-term unsupervised use.

Dosage

As directed by the Physician.